ZBH · Insider Trading
Zimmer Biomet Holdings, Inc.
Every open-market purchase and sale reported by ZBH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Gary Craig Campbell | President, Americas | MIXED | +2,174 | −$124.85K |
| 2026-10-02 | Arthur J Higgins | Director | A | +306 deriv. | — |
| 2026-10-02 | Maria Teresa Hilado | Director | A | +375 deriv. | — |
| 2026-10-02 | Sreelakshmi Kolli | Director | A | +173 deriv. | — |
| 2026-10-02 | Devdatt Kurdikar | Director | A | +173 deriv. | — |
| 2026-10-02 | Louis Shapiro | Director | A | +153 deriv. | — |
| 2026-10-02 | Michael J. Farrell | Director | A | +417 deriv. | — |
| 2026-10-02 | Robert Hagemann | Director | A | +306 deriv. | — |
| 2026-09-15 | Kevin R Thornal | Grp Pres-Global Business | Sell | −5,691 | −$528.98K |
| 2026-09-09 | Chad F Phipps | See remarks below. | Sell | −3,000 | −$295.05K |
| 2026-08-05 | Chintan Desai | President, APAC | A | +10,168 deriv. | — |
| 2026-08-04 | Kevin R Thornal | Grp Pres-Global Business | MIXED | +5,691 | −$395.37K |
| 2026-07-02 | Louis Shapiro | Director | A | +158 deriv. | — |
| 2026-07-02 | Arthur J Higgins | Director | A | +317 deriv. | — |
| 2026-07-02 | Michael J. Farrell | Director | A | +432 deriv. | — |
| 2026-07-02 | Devdatt Kurdikar | Director | A | +180 deriv. | — |
| 2026-07-02 | Maria Teresa Hilado | Director | A | +389 deriv. | — |
| 2026-07-02 | Sreelakshmi Kolli | Director | A | +180 deriv. | — |
| 2026-07-02 | Robert Hagemann | Director | A | +317 deriv. | — |
| 2026-06-03 | Jehanzeb Noor | See remarks below. | A | +1,857 deriv. | — |
| 2026-06-02 | Sang Yi | Group President, Asia Pacific | Sell | −5,000 | −$413.22K |
| 2026-05-27 | Robert Hagemann | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Arthur J Higgins | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Syed A. Jafry | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Sreelakshmi Kolli | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Devdatt Kurdikar | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Louis Shapiro | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Maria Teresa Hilado | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Betsy J Bernard | Director | A | +2,392 deriv. | — |
| 2026-05-27 | Michael J. Farrell | Director | A | +2,392 deriv. | — |
| 2026-05-05 | Paul A Stellato | VP, Controller, CAO | A | +9,232 deriv. | — |
| 2026-04-03 | Jehanzeb Noor | See remarks below. | MIXED | +4,949 | −$152.05K |
| 2026-04-02 | Michael J. Farrell | Director | A | +420 deriv. | — |
| 2026-04-02 | Robert Hagemann | Director | A | +308 deriv. | — |
| 2026-04-02 | Devdatt Kurdikar | Director | A | +154 deriv. | — |
| 2026-04-02 | Arthur J Higgins | Director | A | +308 deriv. | — |
| 2026-04-02 | Maria Teresa Hilado | Director | A | +378 deriv. | — |
| 2026-04-02 | Louis Shapiro | Director | A | +154 deriv. | — |
| 2026-04-02 | Sreelakshmi Kolli | Director | A | +175 deriv. | — |
| 2026-04-02 | Syed A. Jafry | Director | A | +182 deriv. | — |
| 2026-03-16 | Lori Winkler | SVP and CHRO | Sell | −2,650 | −$250.85K |
| 2026-03-10 | Ivan Tornos | Chairman, President and CEO | MIXED | +15,509 | −$1.78M |
| 2026-03-10 | Chad F Phipps | See remarks below. | MIXED | +4,054 | −$252.82K |
| 2026-03-10 | Paul A Stellato | VP, Controller, CAO | MIXED | +1,055 | −$84.67K |
| 2026-03-10 | Sang Yi | Group President, Asia Pacific | M | +9,414 | — |
| 2026-03-10 | Lori Winkler | SVP and CHRO | MIXED | +3,456 | −$201.55K |
| 2026-03-10 | Wilfred Van Zuilen | Group Pres, EMEA | MIXED | +5,182 | −$168.61K |
| 2026-03-10 | Suketu Upadhyay | Exec VP, CFO | MIXED | +8,200 | −$608.54K |
| 2026-02-27 | Paul A Stellato | VP, Controller, CAO | MIXED | +418 | −$40.00K |
| 2026-02-27 | Ivan Tornos | Chairman, President and CEO | MIXED | +8,533 | −$1.05M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Ivan Tornos | Chairman, President and CEO | 78,602 | $7.58M |
| Suketu Upadhyay | Exec VP, CFO | 69,485 | $6.70M |
| Chad F Phipps | See remarks below. | 65,231 | $6.29M |
| Wilfred Van Zuilen | Group Pres, EMEA | 30,652 | $2.95M |
| Sang Yi | Group President, Asia Pacific | 27,251 | $2.63M |
| Mark Bezjak | President, Americas | 13,772 | $1.33M |
| Rachel Ellingson | Chief Administrative Officer | 11,906 | $1.15M |
| Lori Winkler | SVP and CHRO | 10,224 | $985.49K |
| Paul A Stellato | VP, Controller, CAO | 5,864 | $565.23K |
| Betsy J Bernard | Director | 5,271 | $508.07K |
| Jehanzeb Noor | See remarks below. | 5,151 | $496.50K |
| Syed A. Jafry | Director | 4,060 | $391.34K |
| Robert Hagemann | Director | 4,000 | $385.56K |
| Christopher B Begley | Director | 3,540 | $341.22K |
| Arthur J Higgins | Director | 2,900 | $279.53K |
| Gary Craig Campbell | President, Americas | 2,368 | $228.25K |
| Michael J. Farrell | Director | 2,000 | $192.78K |
| Maria Teresa Hilado | Director | 1,650 | $159.04K |
| Sreelakshmi Kolli | Director | 1,000 | $96.39K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ZBH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.